Morgan Stanley Reports On Psychedelics: A Potential Long-Term Investment Portfolio For An Emerging Market
Counterpoint Global is Morgan Stanley’s (NYSE: MS) Investment Management division in charge of understanding new or “disruptive” market opportunities that hold “the potential to trigger far-reaching consequences” and therefore constitute a likely sound, long-term i
